A symptom-based approach to pharmacologic management of fibromyalgia (Q37428736)

20 August 2017

1 reference

title

A symptom-based approach to pharmacologic management of fibromyalgia (English)

1 reference

20 August 2017

0 references

1 reference

2

Leslie J Crofford

1 reference

20 August 2017

Chad S Boomershine

1

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Nature Reviews Rheumatology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

191-199

1 reference

A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The relationship between fibromyalgia and the multiple chemical sensitivity syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

First pregabalin and now duloxetine for fibromyalgia syndrome: closer to a brave new world?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

31 March 2020

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Approved and investigational uses of modafinil : an evidence-based review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Modafinil treatment for fatigue associated with fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Modafinil for the treatment of fatigue of fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Hypothesis: bipolar illness with complaints of chronic musculoskeletal pain is a form of pseudofibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Ropinirole, open preliminary observations of a dopamine agonist for refractory fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Complex sleep apnea syndrome: is it a unique clinical syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Pharmacologic and nonpharmacologic treatments of insomnia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

The relationship of alpha and delta EEG frequencies to pain and mood in ‘fibrositis’ patients treated with chlorpromazine and l-tryptophan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

An open-label study of quetiapine in the treatment of fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Venlafaxine Treatment of Fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Open trial of mirtazapine in patients with fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A critique of the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Update on fibromyalgia therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Pharmacological treatment of fibromyalgia and other chronic musculoskeletal pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.25

Sleep-promoting properties of quetiapine in healthy subjects

31 March 2020

1 reference

12 December 2020

The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

1 reference

12 December 2020

Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

1 reference

12 December 2020

Choosing a skeletal muscle relaxant

1 reference

12 December 2020

Modafinil in fibromyalgia treatment

1 reference

12 December 2020

Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.

1 reference

12 December 2020

Fibromyalgia and cognition

1 reference

12 December 2020

SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants

1 reference

12 December 2020

Pharmacotherapy for patients with fibromyalgia.

1 reference

12 December 2020

The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire

1 reference

12 December 2020

Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia

1 reference

12 December 2020

Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.25

1 reference

20 August 2017

1 reference